Author:
Taher Ali,Cappellini Maria D.,Vichinsky Elliott,Galanello Renzo,Piga Antonio,Lawniczek Tomasz,Clark Joan,Habr Dany,Porter John B.
Reference13 articles.
1. Serum ferritin concentration in sickle cell crisis;Brownell;Journal of Clinical Pathology,1986
2. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia;Cappellini;Blood,2006
3. Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major;Cohen;Blood,2008
4. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in paediatric patients with β-thalassaemia major;Galanello;Haematologica,2006
5. Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial;Nisbet-Brown;Lancet,2003
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献